# The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

> **NCT05874830** · NA · UNKNOWN · sponsor: **Turku University Hospital** · enrollment: 36 (estimated)

## Conditions studied

- IBS - Irritable Bowel Syndrome
- Microbial Substitution

## Interventions

- **OTHER:** Fecal microbiota transplant or plasebo through endoscopy

## Key facts

- **NCT ID:** NCT05874830
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-15
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05874830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05874830, "The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05874830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*